News
· Q2 Sequential Revenue Growth Meets Quarterly Guidance of 2%-5%

15 October 2024

News
Vendaje AC to launch across MAC regions nationwide through Venture Medical, the Company’s exclusive sales and marketing partner for AmnioWrap2®

15 October 2024

News
KLTO strengthens team with industry veteran and is poised to accelerate the development of its therapeutic candidates

15 October 2024

News
· Patent application covers key technology innovations for delivering therapeutic agents

15 October 2024

News
New York, October 14, 2024 - PRISM MediaWire - BigBear.ai (NYSE: BBAI) announced today that it has been awarded a five-year, $165.15M sole-source prime contract from the U.S. Army for Global Force Information Management (GFIM) Production Services.

14 October 2024

News
NEW YORK, October 14, 2024 - PRISM MediaWire - JP 3E Holdings, Inc. (OTC: SPZI), formerly Spooz, Inc., is excited to announce a series of significant corporate developments that mark a new era of growth and expansion for the company. These strategic initiatives include s...

14 October 2024

News
New York, October 11, 2024 - PRISM MediaWire - Upstart (Nasdaq: UPST), an AI-driven lending marketplace, has announced a significant loan purchase agreement with funds managed by Blue Owl Capital. Under the terms of the deal, Blue Owl’s Alternative Credit strategy will a...

11 October 2024

News
PITTSBURGH, Oct. 09, 2024 - PRISM MediaWire - Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced that CEO Jonathan Kaufman,...

9 October 2024

News
MIAMI, Oct. 09, 2024 - PRISM MediaWire - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and which owns over 60 lighting and home décor websites with ...

9 October 2024

News
· Results published in peer-reviewed journal, Clinical Cancer Research

8 October 2024

2
3
4
5
6
7
8
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.